Notably, in lung cancer,56,62,88,121 hepatocellular carcinoma (HCC),39,122−124 and breast cancer,84,85 SIRT5 displays a dichotomousrole, further indicating that its activity is dependent strictly onthe specific context and not only the type of tissue or cancer. Here, SIRT5 is linked to breast carcinoma.